Tag: #diabetes

Tirzepatide shows broader heart-and-kidney edge over dulaglutide in diabetes trial analysis

A post hoc look at the 13,000-patient SURPASS-CVOT trial finds fewer combined heart and kidney events with tirzepatide than dulaglutide.

#diabetes, #cardiology, #glp1, #kidneydisease, #clinicaltrials

Finerenone Cuts Proteinuria in Type 1 Diabetes Kidney Disease Trial, but Long-Term Benefit Unproven

A phase 3 trial found finerenone lowered urine protein in adults with type 1 diabetes and CKD—raising hopes, but leaving outcome questions.

#diabetes, #kidneydisease, #clinicaltrials, #finerenone, #nephrology

Lilly’s daily GLP-1 pill beats Novo’s oral semaglutide in diabetes trial, but side effects drive more dropouts

A Phase 3 head-to-head study finds Lilly’s orforglipron lowered A1c and weight more than Rybelsus, with higher quit rates.

#diabetes, #glp1, #weightloss, #pharma, #clinicaltrials

Stanford Researchers Achieve Breakthrough in Type 1 Diabetes Cure Using Dual-Transplant Approach

Stanford scientists succeed in curing Type 1 diabetes in mice with a novel dual-transplant method, paving the way for human trials.

#diabetes, #stanford, #medicalresearch, #immunotherapy

Pfizer Acquires Metsera in $10 Billion Deal, Re-Enters Obesity Drug Market

Pfizer acquires Metsera for $10B, marking a strategic move into the obesity drug market. The acquisition positions Pfizer against Novo Nordisk and Eli Lilly.

#pfizer, #acquisition, #pharmaceutical, #obesity, #diabetes

WHO Updates Essential Medicines List to Include New Cancer and Diabetes Treatments

WHO adds new cancer and diabetes medicines to its essential list, aiming to improve global health access.

#who, #essentialmedicines, #cancer, #diabetes, #globalhealth

New Biomarkers Unveil Ultraprocessed Food Consumption Impact

Study reveals biomarkers for measuring ultraprocessed food intake, linking it to health risks like diabetes and cancer.

#ultraprocessedfoods, #biomarkers, #healthrisks, #diabetes, #nutrition